Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -7.36%17.89B | 6.81%16.81B | 19.79%20.75B | 12.70%19.04B | 16.90%19.32B | 6.06%15.74B | 3.51%17.33B | -10.31%16.89B | 0.66%16.52B | -6.24%14.84B |
Notes receivable and accounts receivable | -17.76%9.44B | -22.15%9.21B | -30.72%9.2B | -35.58%9.07B | -19.38%11.47B | -20.84%11.83B | 34.81%13.28B | 31.16%14.09B | 9.35%14.23B | 18.97%14.94B |
-Notes receivable | -29.99%12.19M | 1,450.84%9.68M | 259.12%14.19M | 91.63%10.02M | 124.02%17.41M | -82.69%624.25K | 29.61%3.95M | -98.70%5.23M | -99.62%7.77M | -99.79%3.61M |
-Accounts receivable | -17.74%9.42B | -22.23%9.2B | -30.81%9.19B | -35.63%9.06B | -19.46%11.46B | -20.83%11.83B | 34.81%13.28B | 36.22%14.08B | 29.81%14.22B | 37.65%14.94B |
Other receivables (including interest and dividends) | 480.77%447.74M | 889.23%717.84M | -4.56%248.06M | 24.32%61.76M | 53.36%77.09M | -78.33%72.57M | 30.38%259.92M | -55.69%49.68M | -56.21%50.27M | 528.14%334.93M |
-Dividend receivable | -60.07%8.23M | 1,396.48%303.67M | -56.85%93.2M | --3.83M | 20.88%20.62M | -92.97%20.29M | 578.00%215.99M | ---- | 529.21%17.06M | 2,633.53%288.73M |
-Other receivable | ---- | ---- | ---- | 16.61%57.93M | ---- | 13.16%52.27M | ---- | -54.60%49.68M | ---- | 8.03%46.19M |
Contractual assets | 66.55%4.89B | 12.80%3.46B | 71.32%5.22B | 36.34%4.81B | -20.18%2.94B | 7.29%3.07B | -31.47%3.04B | 18.92%3.53B | 17.92%3.68B | -14.52%2.86B |
Advance payment | 20.40%25.17B | 19.82%22.71B | -0.92%19.93B | 10.50%20.15B | 5.88%20.91B | 8.26%18.95B | 13.14%20.12B | -6.88%18.24B | -0.99%19.75B | 0.78%17.51B |
Inventories | 0.84%19.56B | -1.31%20.3B | 19.27%20.83B | 8.49%19.68B | 11.37%19.4B | 15.74%20.57B | 12.50%17.46B | 21.88%18.14B | 12.73%17.42B | 16.57%17.78B |
Other current assets | -15.25%1.89B | -10.02%2.3B | 0.19%2.26B | 19.15%2.39B | 11.06%2.23B | 13.73%2.55B | -10.90%2.25B | -25.72%2B | -40.83%2B | -36.92%2.24B |
Total current assets | 3.90%79.31B | 3.74%75.51B | 6.36%78.44B | 3.11%75.2B | 3.64%76.34B | 3.24%72.79B | 9.96%73.75B | 4.46%72.94B | 3.09%73.65B | 3.74%70.5B |
Non Current assets | ||||||||||
Debt investment | 9.53%59.77M | 9.53%59.77M | 0.00%54.57M | 0.00%54.57M | 11.55%54.57M | 11.55%54.57M | 44.59%54.57M | 44.59%54.57M | 29.62%48.92M | 29.62%48.92M |
Other equity investment | 18.52%661.72M | 18.52%661.72M | -16.91%535.73M | -16.91%535.73M | -2.02%558.3M | -2.02%558.3M | 6.61%644.76M | 6.61%644.76M | -3.45%569.82M | -3.45%569.82M |
Investment real estate | -20.18%110.8M | -22.87%113.73M | -21.99%121.44M | -20.06%130.16M | -19.07%138.81M | -18.30%147.45M | -30.36%155.68M | -29.43%162.83M | -24.35%171.52M | -11.93%180.47M |
Long-term equity investment | 6.65%16.16B | 7.88%15.64B | 10.55%15.57B | 7.29%15.79B | 7.06%15.15B | 6.13%14.49B | 3.12%14.08B | 13.11%14.71B | 10.42%14.15B | 9.63%13.66B |
Fixed assets | ---- | ---- | ---- | 5.95%265.38B | ---- | 5.98%246.68B | ---- | 5.93%250.48B | ---- | -2.93%232.76B |
Constru in process | ---- | ---- | ---- | -23.83%38.04B | ---- | -17.53%56.32B | ---- | -18.28%49.95B | ---- | 18.65%68.3B |
Intangible assets | 22.41%6.55B | 12.17%6.11B | 7.35%5.74B | -0.38%5.28B | 2.81%5.35B | 4.62%5.45B | 6.50%5.35B | 4.59%5.3B | 2.15%5.21B | 0.05%5.21B |
Development expenditure | 8.47%6.99B | 19.88%7.35B | 29.82%7.01B | 31.40%6.88B | 24.64%6.44B | 21.81%6.13B | 22.81%5.4B | 25.04%5.23B | 40.85%5.17B | 40.71%5.03B |
Goodwill | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M | 0.00%419.24M |
Long deferred expense | 9.35%1.85B | 7.12%1.79B | 5.97%1.74B | 5.92%1.72B | 1.91%1.69B | 7.01%1.67B | 5.16%1.64B | 5.08%1.62B | 8.50%1.66B | 2.37%1.56B |
Deferred tax assets | 5.52%2.71B | 4.68%2.67B | 9.77%2.64B | 6.23%2.6B | 5.20%2.57B | 6.07%2.55B | 0.06%2.41B | -0.41%2.45B | 5.65%2.44B | 4.18%2.41B |
Usufruct assets | 41.18%1.17B | 43.02%1.23B | -3.29%880.05M | -19.92%757.67M | -16.13%827.12M | -17.45%860.09M | -9.32%910M | -8.84%946.09M | 0.39%986.19M | 0.11%1.04B |
Other non current assets | 39.40%8.63B | 3.30%7.35B | -24.53%6.05B | -26.96%6.01B | -20.64%6.19B | -2.76%7.12B | 10.53%8.01B | 1.85%8.23B | 9.25%7.8B | -0.45%7.32B |
Total non current assets | 2.99%353.09B | 2.56%351.25B | 0.84%343.06B | 1.00%343.59B | 1.12%342.84B | 1.17%342.46B | 1.54%340.19B | 1.78%340.2B | 2.20%339.04B | 1.94%338.51B |
Total assets | 3.15%432.4B | 2.77%426.75B | 1.83%421.5B | 1.37%418.8B | 1.57%419.18B | 1.52%415.25B | 2.94%413.94B | 2.24%413.14B | 2.35%412.69B | 2.25%409.02B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 50.34%26.73B | 21.11%17.26B | 25.28%17.63B | 33.05%16.31B | 24.65%17.78B | 19.48%14.25B | -2.83%14.07B | -18.34%12.26B | -11.41%14.26B | -27.14%11.93B |
Notes payable and accounts payable | -7.18%25.3B | -11.27%26.86B | -9.30%25.61B | -12.83%23.22B | 1.68%27.26B | 7.87%30.27B | 19.81%28.23B | 24.81%26.64B | 21.46%26.81B | 25.46%28.06B |
-Notes payable | 14.85%5.95B | -2.46%6.66B | -14.10%4.96B | -32.43%3.09B | 28.06%5.18B | 34.12%6.83B | 64.18%5.77B | 77.12%4.58B | 30.96%4.05B | 43.51%5.09B |
-Accounts payable | -12.35%19.35B | -13.84%20.19B | -8.06%20.65B | -8.76%20.13B | -3.02%22.07B | 2.04%23.44B | 12.03%22.46B | 17.60%22.06B | 19.91%22.76B | 22.05%22.97B |
Contract liabilities | 136.04%7.69B | 172.14%7.75B | 26.46%4.4B | 6.26%3.17B | 8.53%3.26B | 4.92%2.85B | 13.28%3.48B | -14.00%2.98B | -31.73%3B | -34.21%2.71B |
Advance receipts | 26.00%1.35M | -0.00%428.57K | --0 | 0.00%642.86K | --1.07M | -4.76%428.57K | 0.00%1.35M | 0.00%642.86K | --0 | --450K |
Salaries payable | -11.68%62.17M | -1.75%56.48M | -14.12%281.7M | -24.80%54.63M | 9.48%70.39M | 0.35%57.49M | 294.40%328M | -32.62%72.65M | -16.56%64.3M | 2.58%57.29M |
Taxs payable | 5.40%1.64B | 69.58%1.94B | 8.24%1.61B | -11.09%1.68B | -17.76%1.56B | -45.54%1.14B | -25.00%1.49B | 12.21%1.89B | 16.04%1.89B | 34.48%2.1B |
Other payable (including interest and dividends) | 6.78%3.98B | 26.49%5.95B | -19.85%5.31B | -10.94%9.04B | -35.59%3.73B | -30.34%4.71B | 44.14%6.62B | 19.31%10.15B | 55.44%5.79B | 65.78%6.76B |
-Dividend payable | 34.77%2.22B | --718.84M | 0.73%1.35B | -4.26%5.94B | -38.96%1.64B | --0 | -10.96%1.34B | -0.45%6.2B | 4.71%2.69B | 40.80%1.14B |
-Other payable | ---- | ---- | ---- | -21.43%3.11B | ---- | -16.22%4.71B | ---- | 73.30%3.95B | ---- | 71.97%5.62B |
Non current liabilities due within one year | -37.06%17.14B | -12.21%21.03B | 19.63%25.13B | 13.04%25B | 20.64%27.23B | 12.10%23.96B | -7.60%21B | -1.50%22.12B | 4.41%22.57B | -5.94%21.37B |
Other current liabilities | 538.98%1.2B | 1,687.69%2.71B | 1,322.46%2.68B | 36.12%2.7B | -90.56%187.29M | -95.17%151.73M | -91.90%188.59M | -49.84%1.98B | -50.06%1.98B | -47.98%3.14B |
Total current liabilities | 3.30%83.73B | 7.99%83.57B | 9.59%82.65B | 3.95%81.19B | 6.14%81.06B | 1.65%77.39B | 3.51%75.42B | 2.04%78.11B | 3.78%76.37B | -1.54%76.13B |
Current liabilities | ||||||||||
Long term loan | -0.53%157.96B | -2.19%155.78B | -3.90%154.46B | -0.65%158.39B | -1.05%158.8B | -0.50%159.27B | 2.07%160.73B | 1.46%159.43B | 0.66%160.48B | 2.66%160.07B |
Bonds payable | --4.8B | -4.02%2.4B | -4.01%2.4B | ---- | --0 | -44.41%2.5B | -44.37%2.5B | -64.28%2.5B | -35.67%4.49B | -24.98%4.49B |
Long term salaries pay | -2.71%48.75M | -25.35%48.75M | -32.35%37.06M | -41.08%35.34M | -9.69%50.11M | 7.44%65.3M | -19.75%54.78M | -49.24%59.98M | -70.24%55.48M | -68.90%60.78M |
Estimate liabilities | 6.73%7.09B | 6.75%6.99B | 7.62%6.84B | 7.93%6.77B | 8.27%6.64B | 9.94%6.55B | 12.29%6.35B | 13.35%6.27B | 13.61%6.13B | 11.72%5.96B |
Deferred tax liabilities | 7.64%1.6B | 3.26%1.5B | 4.29%1.53B | 3.91%1.51B | 6.58%1.49B | 4.94%1.45B | 3.72%1.46B | 7.67%1.45B | 8.85%1.4B | 9.24%1.39B |
Long term deferred income | -10.19%2.01B | -6.63%2.09B | -6.23%2.14B | -4.32%2.22B | -1.73%2.24B | -3.75%2.24B | -0.82%2.28B | 1.39%2.32B | -2.20%2.28B | -1.52%2.33B |
Lease liabilities | 77.36%827.91M | 77.45%856.79M | 10.98%549.3M | -15.69%436.39M | -18.57%466.81M | -25.87%482.83M | -23.73%494.96M | -22.43%517.63M | -4.69%573.26M | -5.91%651.29M |
Total non current liabilities | 2.74%174.34B | -1.67%169.67B | -3.41%167.95B | -1.85%169.35B | -3.26%169.69B | -1.37%172.56B | 1.06%173.88B | -0.88%172.54B | -0.45%175.42B | 1.86%174.95B |
Total liabilities | 2.92%258.07B | 1.32%253.24B | 0.52%250.6B | -0.04%250.54B | -0.41%250.75B | -0.45%249.95B | 1.79%249.29B | 0.01%250.65B | 0.79%251.78B | 0.80%251.08B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B | 0.00%50.5B |
Capital reserve funds | 0.48%10.85B | 11.58%12.04B | -0.10%10.8B | -0.31%10.8B | -0.20%10.8B | -0.12%10.79B | 0.11%10.81B | 0.24%10.83B | 0.23%10.82B | 0.16%10.81B |
Surplus reserve funds | 3.83%6.93B | 3.83%6.93B | 16.32%6.68B | 16.32%6.68B | 16.32%6.68B | 16.32%6.68B | 17.12%5.74B | 17.12%5.74B | 17.12%5.74B | 17.11%5.74B |
Retained profit | 10.89%53.27B | 13.07%50.24B | 12.00%49.67B | 12.48%46.79B | 12.96%48.04B | 13.82%44.43B | 14.57%44.34B | 16.15%41.6B | 15.01%42.53B | 14.29%39.04B |
Other composite income | 10.35%817.29M | 19.99%875.15M | -30.52%643.73M | -23.06%741.33M | 13.08%740.61M | -1.67%729.36M | -2.03%926.46M | 57.62%963.57M | 99.68%654.94M | 114.70%741.76M |
Specific reserves | -37.94%125.6M | -53.17%48.9M | 9.29%162.32M | -31.82%158.37M | -16.08%202.38M | -47.83%104.42M | -27.38%148.52M | 14.09%232.3M | -8.32%241.17M | -19.74%200.14M |
Shareholders equity without minority interests | 4.73%122.49B | 6.54%120.64B | 5.32%118.45B | 5.28%115.67B | 5.86%116.95B | 5.80%113.24B | 6.05%112.47B | 6.84%109.87B | 6.47%110.48B | 6.03%107.03B |
Minority interests | 0.71%51.84B | 1.55%52.87B | 0.53%52.46B | -0.06%52.59B | 2.08%51.47B | 2.28%52.07B | 2.02%52.18B | 3.94%52.63B | 1.60%50.42B | 1.80%50.91B |
Total shareholder equity | 3.50%174.33B | 4.97%173.51B | 3.80%170.9B | 3.55%168.26B | 4.67%168.43B | 4.67%165.3B | 4.74%164.64B | 5.88%162.49B | 4.90%160.91B | 4.63%157.93B |
Total liabilityies and equity | 3.15%432.4B | 2.77%426.75B | 1.83%421.5B | 1.37%418.8B | 1.57%419.18B | 1.52%415.25B | 2.94%413.94B | 2.24%413.14B | 2.35%412.69B | 2.25%409.02B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.